Company Monitoring Page for biotech

latest headlines for company on cafepharma

Fri, 12/14/18 - 10:03 am
Tags:
incubators, biotech
How Indian biotech is driving innovation
Nature
Wed, 12/12/18 - 06:39 pm
Tags:
India, innovation, biotech
Too much success? A booming biotech pipeline will spur intense rivalries — analyst
Endpoints
Tue, 12/11/18 - 10:20 am
Tags:
drug development, biotech, competition
Nasdaq celebrates record biotech IPO success in 2018. But can the party on Wall Street rumba on?
Endpoints
Mon, 12/10/18 - 09:58 am
Tags:
IPOs, biotech, NASDAQ
Could These Be the Next 2 Biotech Buyouts?
Motley Fool
Sun, 12/9/18 - 03:41 pm
Tags:
biotech, M&A, Agios Pharmaceuticals, Clovis Oncology
Moderna, largest biotech to go public, fails to impress in market debut
Reuters
Sat, 12/8/18 - 12:29 pm
Tags:
IPOs, biotech, Moderna Therapeutics
BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation
Businesswire
Thu, 11/29/18 - 10:19 am
Tags:
BIO, biotech, start-ups, taxes, R&D
Can a biotech unicorn break into the record books with a $600M IPO? Stéphane Bancel has a fortune riding on the answer
Endpoints
Wed, 11/28/18 - 11:50 am
Tags:
Moderna, biotech, IPOs, Stephane Bancel
The flip side of the hot IPO market? A chill could trigger a sudden cash crunch in biotech, followed by more deals
Endpoints
Wed, 11/28/18 - 09:57 am
Tags:
biotech, IPOs
In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing
Endpoints
Tue, 11/27/18 - 11:29 pm
Tags:
biotech, reverse merger, M&A, Arsanis, X4 Pharma
Biotech Showcase Conference Reveals Six Therapeutic Areas Receiving the Most Investment Attention in 2019
CP Wire
Tue, 11/27/18 - 12:02 pm
Tags:
biotech, Alzheimer's disease, NASH, RNA, gene therapy, immuno-oncology, orphan diseases
Chinese foothold in U.S. biotech is growing, USTR report finds
BioCentury
Fri, 11/23/18 - 01:17 pm
Tags:
China, biotech
California, Massachusetts go toe-to-toe for title of best biotech hub
Biopharma Dive
Wed, 11/14/18 - 04:36 pm
Tags:
California, Massachusetts, biotech
Preclinical biotech Synthorx wants a $100M IPO
Fierce Biotech
Wed, 11/14/18 - 11:51 am
Tags:
IPOs, biotech, Synthorx, immuno-oncology, cytokines
A 29-Year-Old CEO Who's Shaking Up Diagnostics & Other Stories From The 2019 Healthcare 30 Under 30
Forbes
Tue, 11/13/18 - 09:53 am
Tags:
diagnostics, Healthcare, biotech, CRISPR, entrepreneurs
Moderna aims to raise $500 million in biotech’s largest-ever public offering
Stat
Sat, 11/10/18 - 12:57 pm
Tags:
Moderna Therapeutics, IPOs, biotech
BIO Celebrates 300 Biotech IPOs since Enactment of the JOBS Act
Biotech Now
Sat, 11/10/18 - 12:04 pm
Tags:
JOBS Act, IPOs, biotech
Biotech's big-bucks buybacks begin to burn
EP Vantage
Fri, 11/9/18 - 12:06 pm
Tags:
investors, biotech, Big Biotech, stock buybacks
Harvard gets $200M gift to accelerate early-stage R&D
Fierce Biotech
Fri, 11/9/18 - 11:36 am
Tags:
R&D, Harvard, biotech, incubators
AbbVie hatches plans for a major new R&D hub close to its partners in Bay Area's buzzy Oyster Point
Endpoints
Thu, 11/8/18 - 12:09 pm
Tags:
AbbVie, San Francisco, Oyster Point, biotech

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.